1	4	_	_	CD	_	_	_	_	_
2	.	_	_	.	_	_	_	_	_


1	Discussion	_	_	NN	_	_	_	_	_


1	Considering	_	_	VBG	_	_	_	_	_
2	the	_	_	DT	_	_	_	_	_
3	properties	_	_	NNS	_	_	_	_	_
4	and	_	_	CC	_	_	_	_	_
5	biological	_	_	JJ	_	_	_	_	_
6	role	_	_	NN	_	_	_	_	_
7	of	_	_	IN	_	_	_	_	_
8	silicon	_	_	NN	_	_	_	_	_
9	,	_	_	,	_	_	_	_	_
10	we	_	_	PRP	_	_	_	_	_
11	evaluated	_	_	VBD	_	_	_	_	_
12	the	_	_	DT	_	_	_	_	_
13	effects	_	_	NNS	_	_	_	_	_
14	of	_	_	IN	_	_	_	_	_
15	nutritional	_	_	JJ	_	_	_	_	_
16	supplementation	_	_	NN	_	_	_	_	_
17	with	_	_	IN	_	_	_	_	_
18	silicon-enriched	_	_	JJ	_	_	_	_	_
19	spirulina	_	_	NN	_	_	_	_	_
20	on	_	_	IN	_	_	_	_	_
21	vascular	_	_	JJ	_	_	_	_	_
22	remodeling	_	_	NN	_	_	_	_	_
23	induced	_	_	VBN	_	_	_	_	_
24	by	_	_	IN	_	_	_	_	_
25	hypertension	_	_	NN	_	_	_	_	_
26	in	_	_	IN	_	_	_	_	_
27	a	_	_	DT	_	_	_	_	_
28	SHR	_	_	NN	_	_	_	_	_
29	rat	_	_	NN	_	_	_	_	_
30	model	_	_	NN	_	_	_	_	_
31	.	_	_	.	_	_	_	_	_


1	Our	_	_	PRP$	_	_	_	_	_
2	study	_	_	NN	_	_	_	_	_
3	showed	_	_	VBD	_	_	_	_	_
4	highly	_	_	RB	_	_	_	_	_
5	beneficial	_	_	JJ	_	_	_	_	_
6	effects	_	_	NNS	_	_	_	_	_
7	including	_	_	VBG	_	_	_	_	_
8	attenuation	_	_	NN	_	_	_	_	_
9	of	_	_	IN	_	_	_	_	_
10	arterial	_	_	JJ	_	_	_	_	_
11	pressure	_	_	NN	_	_	_	_	_
12	and	_	_	CC	_	_	_	_	_
13	improvement	_	_	NN	_	_	_	_	_
14	of	_	_	IN	_	_	_	_	_
15	vascular	_	_	JJ	_	_	_	_	_
16	reactivity	_	_	NN	_	_	_	_	_
17	.	_	_	.	_	_	_	_	_


1	These	_	_	DT	_	_	_	_	_
2	benefits	_	_	NNS	_	_	_	_	_
3	were	_	_	VBD	_	_	_	_	_
4	associated	_	_	VBN	_	_	_	_	_
5	with	_	_	IN	_	_	_	_	_
6	reduction	_	_	NN	_	_	_	_	_
7	in	_	_	IN	_	_	_	_	_
8	arterial	_	_	JJ	_	_	_	_	_
9	thickness	_	_	NN	_	_	_	_	_
10	and	_	_	CC	_	_	_	_	_
11	stiffness	_	_	NN	_	_	_	_	_
12	caused	_	_	VBN	_	_	_	_	_
13	by	_	_	IN	_	_	_	_	_
14	the	_	_	DT	_	_	_	_	_
15	structural	_	_	JJ	_	_	_	_	_
16	remodeling	_	_	NN	_	_	_	_	_
17	of	_	_	IN	_	_	_	_	_
18	the	_	_	DT	_	_	_	_	_
19	aortic	_	_	JJ	_	_	_	_	_
20	wall	_	_	NN	_	_	_	_	_
21	in	_	_	IN	_	_	_	_	_
22	SHR	_	_	NNP	_	_	_	_	_
23	.	_	_	.	_	_	_	_	_


1	They	_	_	PRP	_	_	_	_	_
2	were	_	_	VBD	_	_	_	_	_
3	mainly	_	_	RB	_	_	_	_	_
4	attributable	_	_	JJ	_	_	_	_	_
5	to	_	_	TO	_	_	_	_	_
6	Si	_	_	NN	_	_	_	_	_
7	enrichment	_	_	NN	_	_	_	_	_
8	.	_	_	.	_	_	_	_	_


1	Beneficial	_	_	JJ	_	_	_	_	_
2	and	_	_	CC	_	_	_	_	_
3	safe	_	_	JJ	_	_	_	_	_
4	effects	_	_	NNS	_	_	_	_	_
5	of	_	_	IN	_	_	_	_	_
6	SpSi	_	_	NN	_	_	_	_	_
7	supplementation	_	_	NN	_	_	_	_	_
8	were	_	_	VBD	_	_	_	_	_
9	previously	_	_	RB	_	_	_	_	_
10	reported	_	_	VBN	_	_	_	_	_
11	in	_	_	IN	_	_	_	_	_
12	high	_	_	JJ	_	_	_	_	_
13	fat	_	_	NN	_	_	_	_	_
14	diet-induced	_	_	VBN	_	_	_	_	_
15	models	_	_	NNS	_	_	_	_	_
16	of	_	_	IN	_	_	_	_	_
17	atherosclerosis	_	_	NN	_	_	_	_	_
18	in	_	_	IN	_	_	_	_	_
19	hamsters	_	_	NNS	_	_	_	_	_
20	and	_	_	CC	_	_	_	_	_
21	metabolic	_	_	JJ	_	_	_	_	_
22	syndrome	_	_	NN	_	_	_	_	_
23	in	_	_	IN	_	_	_	_	_
24	rats	_	_	NNS	_	_	_	_	_
25	.	_	_	.	_	_	_	_	_


1	Improvement	_	_	NN	_	_	_	_	_
2	of	_	_	IN	_	_	_	_	_
3	glucose	_	_	NN	_	_	_	_	_
4	tolerance	_	_	NN	_	_	_	_	_
5	,	_	_	,	_	_	_	_	_
6	insulin	_	_	NN	_	_	_	_	_
7	resistance	_	_	NN	_	_	_	_	_
8	,	_	_	,	_	_	_	_	_
9	or	_	_	CC	_	_	_	_	_
10	dyslipidemia	_	_	NN	_	_	_	_	_
11	were	_	_	VBD	_	_	_	_	_
12	evidenced	_	_	VBN	_	_	_	_	_
13	with	_	_	IN	_	_	_	_	_
14	both	_	_	CC	_	_	_	_	_
15	SpSi	_	_	NNP	_	_	_	_	_
16	and	_	_	CC	_	_	_	_	_
17	Sp	_	_	NNP	_	_	_	_	_
18	supplementation	_	_	NN	_	_	_	_	_
19	.	_	_	.	_	_	_	_	_


1	However	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	only	_	_	RB	_	_	_	_	_
4	SpSi	_	_	NNP	_	_	_	_	_
5	had	_	_	VBD	_	_	_	_	_
6	beneficial	_	_	JJ	_	_	_	_	_
7	effects	_	_	NNS	_	_	_	_	_
8	on	_	_	IN	_	_	_	_	_
9	arterial	_	_	JJ	_	_	_	_	_
10	function	_	_	NN	_	_	_	_	_
11	.	_	_	.	_	_	_	_	_


1	No	_	_	DT	_	_	_	_	_
2	toxicity	_	_	NN	_	_	_	_	_
3	or	_	_	CC	_	_	_	_	_
4	side	_	_	NN	_	_	_	_	_
5	effects	_	_	NNS	_	_	_	_	_
6	of	_	_	IN	_	_	_	_	_
7	SpSi	_	_	NNP	_	_	_	_	_
8	supplement	_	_	NN	_	_	_	_	_
9	were	_	_	VBD	_	_	_	_	_
10	otherwise	_	_	RB	_	_	_	_	_
11	observed	_	_	VBN	_	_	_	_	_
12	.	_	_	.	_	_	_	_	_


1	Increase	_	_	NN	_	_	_	_	_
2	of	_	_	IN	_	_	_	_	_
3	arterial	_	_	JJ	_	_	_	_	_
4	stiffness	_	_	NN	_	_	_	_	_
5	,	_	_	,	_	_	_	_	_
6	reduction	_	_	NN	_	_	_	_	_
7	of	_	_	IN	_	_	_	_	_
8	arterial	_	_	JJ	_	_	_	_	_
9	compliance	_	_	NN	_	_	_	_	_
10	,	_	_	,	_	_	_	_	_
11	and	_	_	CC	_	_	_	_	_
12	distensibility	_	_	NN	_	_	_	_	_
13	marked	_	_	VBN	_	_	_	_	_
14	by	_	_	IN	_	_	_	_	_
15	fragmentation	_	_	NN	_	_	_	_	_
16	of	_	_	IN	_	_	_	_	_
17	elastin	_	_	NN	_	_	_	_	_
18	are	_	_	VBP	_	_	_	_	_
19	the	_	_	DT	_	_	_	_	_
20	main	_	_	JJ	_	_	_	_	_
21	consequences	_	_	NNS	_	_	_	_	_
22	of	_	_	IN	_	_	_	_	_
23	arterial	_	_	JJ	_	_	_	_	_
24	remodeling	_	_	NN	_	_	_	_	_
25	occurring	_	_	VBG	_	_	_	_	_
26	in	_	_	IN	_	_	_	_	_
27	hypertension	_	_	NN	_	_	_	_	_
28	,	_	_	,	_	_	_	_	_
29	obesity	_	_	NN	_	_	_	_	_
30	and	_	_	CC	_	_	_	_	_
31	aging	_	_	NN	_	_	_	_	_
32	.	_	_	.	_	_	_	_	_


1	Vascular	_	_	JJ	_	_	_	_	_
2	remodeling	_	_	NN	_	_	_	_	_
3	in	_	_	IN	_	_	_	_	_
4	hypertension	_	_	NN	_	_	_	_	_
5	is	_	_	VBZ	_	_	_	_	_
6	characterized	_	_	VBN	_	_	_	_	_
7	by	_	_	IN	_	_	_	_	_
8	altered	_	_	VBN	_	_	_	_	_
9	ultrastructure	_	_	NN	_	_	_	_	_
10	due	_	_	JJ	_	_	_	_	_
11	to	_	_	TO	_	_	_	_	_
12	reduction	_	_	NN	_	_	_	_	_
13	in	_	_	IN	_	_	_	_	_
14	elastin	_	_	NN	_	_	_	_	_
15	and	_	_	CC	_	_	_	_	_
16	increase	_	_	NN	_	_	_	_	_
17	in	_	_	IN	_	_	_	_	_
18	fibrous	_	_	JJ	_	_	_	_	_
19	tissue	_	_	NN	_	_	_	_	_
20	.	_	_	.	_	_	_	_	_


1	Here	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	we	_	_	PRP	_	_	_	_	_
4	assessed	_	_	VBD	_	_	_	_	_
5	the	_	_	DT	_	_	_	_	_
6	effect	_	_	NN	_	_	_	_	_
7	of	_	_	IN	_	_	_	_	_
8	SpSi	_	_	NNP	_	_	_	_	_
9	on	_	_	IN	_	_	_	_	_
10	the	_	_	DT	_	_	_	_	_
11	ultrastructural	_	_	JJ	_	_	_	_	_
12	,	_	_	,	_	_	_	_	_
13	mechanical	_	_	JJ	_	_	_	_	_
14	and	_	_	CC	_	_	_	_	_
15	functional	_	_	JJ	_	_	_	_	_
16	changes	_	_	NNS	_	_	_	_	_
17	characterized	_	_	VBN	_	_	_	_	_
18	in	_	_	IN	_	_	_	_	_
19	SHR	_	_	NNP	_	_	_	_	_
20	thoracic	_	_	JJ	_	_	_	_	_
21	aorta	_	_	NN	_	_	_	_	_
22	.	_	_	.	_	_	_	_	_


1	These	_	_	DT	_	_	_	_	_
2	modifications	_	_	NNS	_	_	_	_	_
3	consisted	_	_	VBD	_	_	_	_	_
4	of	_	_	IN	_	_	_	_	_
5	(	_	_	-LRB-	_	_	_	_	_
6	i	_	_	CD	_	_	_	_	_
7	)	_	_	-RRB-	_	_	_	_	_
8	arterial	_	_	JJ	_	_	_	_	_
9	wall	_	_	NN	_	_	_	_	_
10	hypertrophy	_	_	NN	_	_	_	_	_
11	,	_	_	,	_	_	_	_	_
12	(	_	_	-LRB-	_	_	_	_	_
13	ii	_	_	NN	_	_	_	_	_
14	)	_	_	-RRB-	_	_	_	_	_
15	fragmentation	_	_	NN	_	_	_	_	_
16	,	_	_	,	_	_	_	_	_
17	linearization	_	_	NN	_	_	_	_	_
18	,	_	_	,	_	_	_	_	_
19	and	_	_	CC	_	_	_	_	_
20	refolding	_	_	NN	_	_	_	_	_
21	of	_	_	IN	_	_	_	_	_
22	elastic	_	_	JJ	_	_	_	_	_
23	fibers	_	_	NNS	_	_	_	_	_
24	,	_	_	,	_	_	_	_	_
25	and	_	_	CC	_	_	_	_	_
26	(	_	_	-LRB-	_	_	_	_	_
27	iii	_	_	CD	_	_	_	_	_
28	)	_	_	-RRB-	_	_	_	_	_
29	impaired	_	_	VBN	_	_	_	_	_
30	contractile	_	_	JJ	_	_	_	_	_
31	and	_	_	CC	_	_	_	_	_
32	vasorelaxant	_	_	JJ	_	_	_	_	_
33	responses	_	_	NNS	_	_	_	_	_
34	.	_	_	.	_	_	_	_	_


1	These	_	_	DT	_	_	_	_	_
2	changes	_	_	NNS	_	_	_	_	_
3	typified	_	_	VBD	_	_	_	_	_
4	the	_	_	DT	_	_	_	_	_
5	degenerative	_	_	JJ	_	_	_	_	_
6	processes	_	_	NNS	_	_	_	_	_
7	leading	_	_	VBG	_	_	_	_	_
8	to	_	_	TO	_	_	_	_	_
9	the	_	_	DT	_	_	_	_	_
10	reduction	_	_	NN	_	_	_	_	_
11	of	_	_	IN	_	_	_	_	_
12	compliance	_	_	NN	_	_	_	_	_
13	and	_	_	CC	_	_	_	_	_
14	distensibility	_	_	NN	_	_	_	_	_
15	described	_	_	VBN	_	_	_	_	_
16	in	_	_	IN	_	_	_	_	_
17	hypertension	_	_	NN	_	_	_	_	_
18	and	_	_	CC	_	_	_	_	_
19	associated	_	_	VBN	_	_	_	_	_
20	with	_	_	IN	_	_	_	_	_
21	aging	_	_	NN	_	_	_	_	_
22	.	_	_	.	_	_	_	_	_


1	Indeed	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	in	_	_	IN	_	_	_	_	_
4	SHR	_	_	NN	_	_	_	_	_
5	aorta	_	_	NN	_	_	_	_	_
6	,	_	_	,	_	_	_	_	_
7	our	_	_	PRP$	_	_	_	_	_
8	results	_	_	NNS	_	_	_	_	_
9	showed	_	_	VBD	_	_	_	_	_
10	enlarged	_	_	VBN	_	_	_	_	_
11	internal	_	_	JJ	_	_	_	_	_
12	diameter	_	_	NN	_	_	_	_	_
13	and	_	_	CC	_	_	_	_	_
14	media	_	_	NN	_	_	_	_	_
15	thickening	_	_	NN	_	_	_	_	_
16	,	_	_	,	_	_	_	_	_
17	increased	_	_	VBN	_	_	_	_	_
18	elastin	_	_	NN	_	_	_	_	_
19	fragmentation	_	_	NN	_	_	_	_	_
20	ratio	_	_	NN	_	_	_	_	_
21	,	_	_	,	_	_	_	_	_
22	and	_	_	CC	_	_	_	_	_
23	lower	_	_	JJR	_	_	_	_	_
24	elastin	_	_	NN	_	_	_	_	_
25	and	_	_	CC	_	_	_	_	_
26	collagen	_	_	NN	_	_	_	_	_
27	levels	_	_	NNS	_	_	_	_	_
28	than	_	_	IN	_	_	_	_	_
29	in	_	_	IN	_	_	_	_	_
30	normotensive	_	_	JJ	_	_	_	_	_
31	animals	_	_	NNS	_	_	_	_	_
32	.	_	_	.	_	_	_	_	_


1	Consequently	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	contractility	_	_	NN	_	_	_	_	_
4	was	_	_	VBD	_	_	_	_	_
5	impaired	_	_	VBN	_	_	_	_	_
6	as	_	_	IN	_	_	_	_	_
7	evidenced	_	_	VBN	_	_	_	_	_
8	by	_	_	IN	_	_	_	_	_
9	the	_	_	DT	_	_	_	_	_
10	decreased	_	_	VBN	_	_	_	_	_
11	response	_	_	NN	_	_	_	_	_
12	and	_	_	CC	_	_	_	_	_
13	sensitivities	_	_	NNS	_	_	_	_	_
14	to	_	_	TO	_	_	_	_	_
15	KCl-induced	_	_	JJ	_	_	_	_	_
16	depolarization	_	_	NN	_	_	_	_	_
17	and	_	_	CC	_	_	_	_	_
18	PE	_	_	NN	_	_	_	_	_
19	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	vasorelaxant	_	_	NN	_	_	_	_	_
3	responses	_	_	NNS	_	_	_	_	_
4	to	_	_	TO	_	_	_	_	_
5	both	_	_	DT	_	_	_	_	_
6	Ach	_	_	NNP	_	_	_	_	_
7	and	_	_	CC	_	_	_	_	_
8	SNP	_	_	NNP	_	_	_	_	_
9	were	_	_	VBD	_	_	_	_	_
10	also	_	_	RB	_	_	_	_	_
11	reduced	_	_	VBN	_	_	_	_	_
12	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	enhanced	_	_	VBN	_	_	_	_	_
3	effect	_	_	NN	_	_	_	_	_
4	of	_	_	IN	_	_	_	_	_
5	L-NAME	_	_	NNP	_	_	_	_	_
6	on	_	_	IN	_	_	_	_	_
7	PE-induced	_	_	JJ	_	_	_	_	_
8	contraction	_	_	NN	_	_	_	_	_
9	suggested	_	_	VBD	_	_	_	_	_
10	that	_	_	IN	_	_	_	_	_
11	the	_	_	DT	_	_	_	_	_
12	decrease	_	_	NN	_	_	_	_	_
13	in	_	_	IN	_	_	_	_	_
14	the	_	_	DT	_	_	_	_	_
15	vasodilator	_	_	NN	_	_	_	_	_
16	capacity	_	_	NN	_	_	_	_	_
17	of	_	_	IN	_	_	_	_	_
18	aorta	_	_	NN	_	_	_	_	_
19	in	_	_	IN	_	_	_	_	_
20	SHR	_	_	NN	_	_	_	_	_
21	is	_	_	VBZ	_	_	_	_	_
22	due	_	_	JJ	_	_	_	_	_
23	to	_	_	TO	_	_	_	_	_
24	both	_	_	CC	_	_	_	_	_
25	the	_	_	DT	_	_	_	_	_
26	alteration	_	_	NN	_	_	_	_	_
27	of	_	_	IN	_	_	_	_	_
28	vascular	_	_	JJ	_	_	_	_	_
29	smooth	_	_	JJ	_	_	_	_	_
30	muscle	_	_	NN	_	_	_	_	_
31	function	_	_	NN	_	_	_	_	_
32	and	_	_	CC	_	_	_	_	_
33	NO	_	_	DT	_	_	_	_	_
34	bioavailability	_	_	NN	_	_	_	_	_
35	.	_	_	.	_	_	_	_	_


1	After	_	_	IN	_	_	_	_	_
2	three	_	_	CD	_	_	_	_	_
3	months	_	_	NNS	_	_	_	_	_
4	of	_	_	IN	_	_	_	_	_
5	supplementation	_	_	NN	_	_	_	_	_
6	,	_	_	,	_	_	_	_	_
7	SpSi	_	_	NNP	_	_	_	_	_
8	substantially	_	_	RB	_	_	_	_	_
9	corrected	_	_	VBD	_	_	_	_	_
10	and	_	_	CC	_	_	_	_	_
11	even	_	_	RB	_	_	_	_	_
12	normalized	_	_	VBD	_	_	_	_	_
13	most	_	_	JJS	_	_	_	_	_
14	of	_	_	IN	_	_	_	_	_
15	the	_	_	DT	_	_	_	_	_
16	defects	_	_	NNS	_	_	_	_	_
17	identified	_	_	VBN	_	_	_	_	_
18	in	_	_	IN	_	_	_	_	_
19	SHR	_	_	NNP	_	_	_	_	_
20	aorta	_	_	NN	_	_	_	_	_
21	.	_	_	.	_	_	_	_	_


1	First	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	aortic	_	_	JJ	_	_	_	_	_
4	hypertrophy	_	_	NN	_	_	_	_	_
5	was	_	_	VBD	_	_	_	_	_
6	reduced	_	_	VBN	_	_	_	_	_
7	as	_	_	IN	_	_	_	_	_
8	shown	_	_	VBN	_	_	_	_	_
9	by	_	_	IN	_	_	_	_	_
10	morphologic	_	_	JJ	_	_	_	_	_
11	analysis	_	_	NN	_	_	_	_	_
12	.	_	_	.	_	_	_	_	_


1	Higher	_	_	JJR	_	_	_	_	_
2	level	_	_	NN	_	_	_	_	_
3	of	_	_	IN	_	_	_	_	_
4	elastin	_	_	NN	_	_	_	_	_
5	fiber	_	_	NN	_	_	_	_	_
6	density	_	_	NN	_	_	_	_	_
7	and	_	_	CC	_	_	_	_	_
8	mRNA	_	_	NN	_	_	_	_	_
9	level	_	_	NN	_	_	_	_	_
10	were	_	_	VBD	_	_	_	_	_
11	associated	_	_	VBN	_	_	_	_	_
12	to	_	_	TO	_	_	_	_	_
13	a	_	_	DT	_	_	_	_	_
14	decrease	_	_	NN	_	_	_	_	_
15	in	_	_	IN	_	_	_	_	_
16	MMP-9	_	_	NNP	_	_	_	_	_
17	expression	_	_	NN	_	_	_	_	_
18	,	_	_	,	_	_	_	_	_
19	suggesting	_	_	VBG	_	_	_	_	_
20	that	_	_	IN	_	_	_	_	_
21	both	_	_	CC	_	_	_	_	_
22	enhanced	_	_	VBN	_	_	_	_	_
23	elastin	_	_	NN	_	_	_	_	_
24	biosynthesis	_	_	NN	_	_	_	_	_
25	and	_	_	CC	_	_	_	_	_
26	reduced	_	_	VBN	_	_	_	_	_
27	extracellular	_	_	JJ	_	_	_	_	_
28	matrix	_	_	NN	_	_	_	_	_
29	contributed	_	_	VBN	_	_	_	_	_
30	to	_	_	TO	_	_	_	_	_
31	media	_	_	NN	_	_	_	_	_
32	thinning	_	_	NN	_	_	_	_	_
33	.	_	_	.	_	_	_	_	_


1	It	_	_	PRP	_	_	_	_	_
2	is	_	_	VBZ	_	_	_	_	_
3	known	_	_	VBN	_	_	_	_	_
4	that	_	_	IN	_	_	_	_	_
5	hypertensive	_	_	JJ	_	_	_	_	_
6	vascular	_	_	JJ	_	_	_	_	_
7	remodeling	_	_	NN	_	_	_	_	_
8	involves	_	_	VBZ	_	_	_	_	_
9	reorganization	_	_	NN	_	_	_	_	_
10	and	_	_	CC	_	_	_	_	_
11	impairment	_	_	NN	_	_	_	_	_
12	of	_	_	IN	_	_	_	_	_
13	the	_	_	DT	_	_	_	_	_
14	extracellular	_	_	JJ	_	_	_	_	_
15	matrix	_	_	NN	_	_	_	_	_
16	and	_	_	CC	_	_	_	_	_
17	that	_	_	IN	_	_	_	_	_
18	MMPs	_	_	NNPS	_	_	_	_	_
19	play	_	_	VBP	_	_	_	_	_
20	an	_	_	DT	_	_	_	_	_
21	important	_	_	JJ	_	_	_	_	_
22	role	_	_	NN	_	_	_	_	_
23	in	_	_	IN	_	_	_	_	_
24	this	_	_	DT	_	_	_	_	_
25	remodeling	_	_	NN	_	_	_	_	_
26	.	_	_	.	_	_	_	_	_


1	Second	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	we	_	_	PRP	_	_	_	_	_
4	observed	_	_	VBD	_	_	_	_	_
5	an	_	_	DT	_	_	_	_	_
6	improvement	_	_	NN	_	_	_	_	_
7	of	_	_	IN	_	_	_	_	_
8	vascular	_	_	JJ	_	_	_	_	_
9	function	_	_	NN	_	_	_	_	_
10	after	_	_	IN	_	_	_	_	_
11	SpSi	_	_	NNP	_	_	_	_	_
12	supplementation	_	_	NN	_	_	_	_	_
13	.	_	_	.	_	_	_	_	_


1	Contractile	_	_	NN	_	_	_	_	_
2	and	_	_	CC	_	_	_	_	_
3	vasorelaxant	_	_	NN	_	_	_	_	_
4	responses	_	_	NNS	_	_	_	_	_
5	were	_	_	VBD	_	_	_	_	_
6	increased	_	_	VBN	_	_	_	_	_
7	in	_	_	IN	_	_	_	_	_
8	association	_	_	NN	_	_	_	_	_
9	with	_	_	IN	_	_	_	_	_
10	an	_	_	DT	_	_	_	_	_
11	increased	_	_	VBN	_	_	_	_	_
12	sensitivity	_	_	NN	_	_	_	_	_
13	to	_	_	TO	_	_	_	_	_
14	the	_	_	DT	_	_	_	_	_
15	agonists	_	_	NNS	_	_	_	_	_
16	and	_	_	CC	_	_	_	_	_
17	antagonists	_	_	NNS	_	_	_	_	_
18	tested	_	_	VBN	_	_	_	_	_
19	and	_	_	CC	_	_	_	_	_
20	a	_	_	DT	_	_	_	_	_
21	better	_	_	JJR	_	_	_	_	_
22	NO	_	_	DT	_	_	_	_	_
23	bioavailability	_	_	NN	_	_	_	_	_
24	.	_	_	.	_	_	_	_	_


1	Finally	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	we	_	_	PRP	_	_	_	_	_
4	found	_	_	VBD	_	_	_	_	_
5	that	_	_	IN	_	_	_	_	_
6	SHR	_	_	NN	_	_	_	_	_
7	animals	_	_	NNS	_	_	_	_	_
8	supplemented	_	_	VBN	_	_	_	_	_
9	with	_	_	IN	_	_	_	_	_
10	SpSi	_	_	NNP	_	_	_	_	_
11	had	_	_	VBD	_	_	_	_	_
12	lower	_	_	JJR	_	_	_	_	_
13	arterial	_	_	JJ	_	_	_	_	_
14	pressure	_	_	NN	_	_	_	_	_
15	than	_	_	IN	_	_	_	_	_
16	control	_	_	NN	_	_	_	_	_
17	SHR	_	_	NN	_	_	_	_	_
18	.	_	_	.	_	_	_	_	_


1	Arterial	_	_	JJ	_	_	_	_	_
2	pressure	_	_	NN	_	_	_	_	_
3	,	_	_	,	_	_	_	_	_
4	although	_	_	IN	_	_	_	_	_
5	significantly	_	_	RB	_	_	_	_	_
6	reduced	_	_	VBN	_	_	_	_	_
7	,	_	_	,	_	_	_	_	_
8	was	_	_	VBD	_	_	_	_	_
9	still	_	_	RB	_	_	_	_	_
10	higher	_	_	JJR	_	_	_	_	_
11	than	_	_	IN	_	_	_	_	_
12	normal	_	_	JJ	_	_	_	_	_
13	pressure	_	_	NN	_	_	_	_	_
14	which	_	_	WDT	_	_	_	_	_
15	may	_	_	MD	_	_	_	_	_
16	explain	_	_	VB	_	_	_	_	_
17	the	_	_	DT	_	_	_	_	_
18	lack	_	_	NN	_	_	_	_	_
19	of	_	_	IN	_	_	_	_	_
20	benefit	_	_	NN	_	_	_	_	_
21	on	_	_	IN	_	_	_	_	_
22	cardiac	_	_	JJ	_	_	_	_	_
23	parameters	_	_	NNS	_	_	_	_	_
24	in	_	_	IN	_	_	_	_	_
25	our	_	_	PRP$	_	_	_	_	_
26	experimental	_	_	JJ	_	_	_	_	_
27	conditions	_	_	NNS	_	_	_	_	_
28	(	_	_	-LRB-	_	_	_	_	_
29	hypertension	_	_	NN	_	_	_	_	_
30	already	_	_	RB	_	_	_	_	_
31	established	_	_	VBN	_	_	_	_	_
32	,	_	_	,	_	_	_	_	_
33	3	_	_	CD	_	_	_	_	_
34	months	_	_	NNS	_	_	_	_	_
35	of	_	_	IN	_	_	_	_	_
36	supplementation	_	_	NN	_	_	_	_	_
37	)	_	_	-RRB-	_	_	_	_	_
38	.	_	_	.	_	_	_	_	_


1	Another	_	_	DT	_	_	_	_	_
2	interesting	_	_	JJ	_	_	_	_	_
3	result	_	_	NN	_	_	_	_	_
4	in	_	_	IN	_	_	_	_	_
5	our	_	_	PRP$	_	_	_	_	_
6	study	_	_	NN	_	_	_	_	_
7	is	_	_	VBZ	_	_	_	_	_
8	that	_	_	IN	_	_	_	_	_
9	supplementation	_	_	NN	_	_	_	_	_
10	with	_	_	IN	_	_	_	_	_
11	Sp	_	_	NNP	_	_	_	_	_
12	alone	_	_	RB	_	_	_	_	_
13	had	_	_	VBD	_	_	_	_	_
14	no	_	_	DT	_	_	_	_	_
15	effect	_	_	NN	_	_	_	_	_
16	in	_	_	IN	_	_	_	_	_
17	SHR	_	_	NN	_	_	_	_	_
18	suggesting	_	_	VBG	_	_	_	_	_
19	that	_	_	IN	_	_	_	_	_
20	the	_	_	DT	_	_	_	_	_
21	benefits	_	_	NNS	_	_	_	_	_
22	observed	_	_	VBN	_	_	_	_	_
23	with	_	_	IN	_	_	_	_	_
24	SpSi	_	_	NNP	_	_	_	_	_
25	are	_	_	VBP	_	_	_	_	_
26	genuine	_	_	JJ	_	_	_	_	_
27	effects	_	_	NNS	_	_	_	_	_
28	of	_	_	IN	_	_	_	_	_
29	Si	_	_	NN	_	_	_	_	_
30	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	nutritional	_	_	JJ	_	_	_	_	_
3	essentiality	_	_	NN	_	_	_	_	_
4	of	_	_	IN	_	_	_	_	_
5	Si	_	_	NN	_	_	_	_	_
6	is	_	_	VBZ	_	_	_	_	_
7	undeniable	_	_	JJ	_	_	_	_	_
8	.	_	_	.	_	_	_	_	_


1	This	_	_	DT	_	_	_	_	_
2	organic	_	_	JJ	_	_	_	_	_
3	element	_	_	NN	_	_	_	_	_
4	appears	_	_	VBZ	_	_	_	_	_
5	as	_	_	IN	_	_	_	_	_
6	an	_	_	DT	_	_	_	_	_
7	important	_	_	JJ	_	_	_	_	_
8	structural	_	_	JJ	_	_	_	_	_
9	component	_	_	NN	_	_	_	_	_
10	of	_	_	IN	_	_	_	_	_
11	the	_	_	DT	_	_	_	_	_
12	aortic	_	_	JJ	_	_	_	_	_
13	wall	_	_	NN	_	_	_	_	_
14	which	_	_	WDT	_	_	_	_	_
15	contributes	_	_	VBZ	_	_	_	_	_
16	to	_	_	TO	_	_	_	_	_
17	elastin	_	_	NN	_	_	_	_	_
18	and	_	_	CC	_	_	_	_	_
19	collagen	_	_	NN	_	_	_	_	_
20	synthesis	_	_	NN	_	_	_	_	_
21	and	_	_	CC	_	_	_	_	_
22	stability	_	_	NN	_	_	_	_	_
23	.	_	_	.	_	_	_	_	_


1	Data	_	_	NNS	_	_	_	_	_
2	from	_	_	IN	_	_	_	_	_
3	animal	_	_	NN	_	_	_	_	_
4	and	_	_	CC	_	_	_	_	_
5	human	_	_	JJ	_	_	_	_	_
6	studies	_	_	NNS	_	_	_	_	_
7	demonstrated	_	_	VBD	_	_	_	_	_
8	that	_	_	IN	_	_	_	_	_
9	dietary	_	_	NN	_	_	_	_	_
10	Si	_	_	NN	_	_	_	_	_
11	mitigates	_	_	VBZ	_	_	_	_	_
12	the	_	_	DT	_	_	_	_	_
13	risk	_	_	NN	_	_	_	_	_
14	of	_	_	IN	_	_	_	_	_
15	cardiovascular	_	_	JJ	_	_	_	_	_
16	diseases	_	_	NNS	_	_	_	_	_
17	.	_	_	.	_	_	_	_	_


1	Si	_	_	NN	_	_	_	_	_
2	in	_	_	IN	_	_	_	_	_
3	drinking	_	_	NN	_	_	_	_	_
4	water	_	_	NN	_	_	_	_	_
5	has	_	_	VBZ	_	_	_	_	_
6	been	_	_	VBN	_	_	_	_	_
7	inversely	_	_	RB	_	_	_	_	_
8	correlated	_	_	VBN	_	_	_	_	_
9	with	_	_	IN	_	_	_	_	_
10	mortality	_	_	NN	_	_	_	_	_
11	rates	_	_	NNS	_	_	_	_	_
12	due	_	_	JJ	_	_	_	_	_
13	to	_	_	TO	_	_	_	_	_
14	coronary	_	_	JJ	_	_	_	_	_
15	heart	_	_	NN	_	_	_	_	_
16	diseases	_	_	NNS	_	_	_	_	_
17	in	_	_	IN	_	_	_	_	_
18	Finland	_	_	NNP	_	_	_	_	_
19	.	_	_	.	_	_	_	_	_


1	Reduced	_	_	VBN	_	_	_	_	_
2	damage	_	_	NN	_	_	_	_	_
3	and	_	_	CC	_	_	_	_	_
4	thickening	_	_	NN	_	_	_	_	_
5	of	_	_	IN	_	_	_	_	_
6	elastic	_	_	JJ	_	_	_	_	_
7	fibers	_	_	NNS	_	_	_	_	_
8	were	_	_	VBD	_	_	_	_	_
9	observed	_	_	VBN	_	_	_	_	_
10	in	_	_	IN	_	_	_	_	_
11	the	_	_	DT	_	_	_	_	_
12	aortic	_	_	JJ	_	_	_	_	_
13	wall	_	_	NN	_	_	_	_	_
14	after	_	_	IN	_	_	_	_	_
15	silicon	_	_	NN	_	_	_	_	_
16	supplementation	_	_	NN	_	_	_	_	_
17	in	_	_	IN	_	_	_	_	_
18	rabbit	_	_	NN	_	_	_	_	_
19	models	_	_	NNS	_	_	_	_	_
20	of	_	_	IN	_	_	_	_	_
21	diet-induced	_	_	JJ	_	_	_	_	_
22	atherosclerosis	_	_	NN	_	_	_	_	_
23	.	_	_	.	_	_	_	_	_


1	Moreover	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	our	_	_	PRP$	_	_	_	_	_
4	results	_	_	NNS	_	_	_	_	_
5	are	_	_	VBP	_	_	_	_	_
6	in	_	_	IN	_	_	_	_	_
7	line	_	_	NN	_	_	_	_	_
8	with	_	_	IN	_	_	_	_	_
9	a	_	_	DT	_	_	_	_	_
10	previous	_	_	JJ	_	_	_	_	_
11	study	_	_	NN	_	_	_	_	_
12	reporting	_	_	VBG	_	_	_	_	_
13	reduction	_	_	NN	_	_	_	_	_
14	in	_	_	IN	_	_	_	_	_
15	systolic	_	_	JJ	_	_	_	_	_
16	arterial	_	_	JJ	_	_	_	_	_
17	pressure	_	_	NN	_	_	_	_	_
18	after	_	_	IN	_	_	_	_	_
19	supplementation	_	_	NN	_	_	_	_	_
20	with	_	_	IN	_	_	_	_	_
21	soluble	_	_	JJ	_	_	_	_	_
22	silicon	_	_	NN	_	_	_	_	_
23	in	_	_	IN	_	_	_	_	_
24	SHR	_	_	NN	_	_	_	_	_
25	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	that	_	_	DT	_	_	_	_	_
3	study	_	_	NN	_	_	_	_	_
4	,	_	_	,	_	_	_	_	_
5	arterial	_	_	JJ	_	_	_	_	_
6	structure	_	_	NN	_	_	_	_	_
7	was	_	_	VBD	_	_	_	_	_
8	not	_	_	RB	_	_	_	_	_
9	investigated	_	_	VBN	_	_	_	_	_
10	and	_	_	CC	_	_	_	_	_
11	enhancement	_	_	NN	_	_	_	_	_
12	of	_	_	IN	_	_	_	_	_
13	intracellular	_	_	JJ	_	_	_	_	_
14	magnesium	_	_	NN	_	_	_	_	_
15	uptake	_	_	NN	_	_	_	_	_
16	was	_	_	VBD	_	_	_	_	_
17	evoked	_	_	VBN	_	_	_	_	_
18	as	_	_	IN	_	_	_	_	_
19	a	_	_	DT	_	_	_	_	_
20	possible	_	_	JJ	_	_	_	_	_
21	mechanism	_	_	NN	_	_	_	_	_
22	.	_	_	.	_	_	_	_	_


1	This	_	_	DT	_	_	_	_	_
2	is	_	_	VBZ	_	_	_	_	_
3	not	_	_	RB	_	_	_	_	_
4	inconsistent	_	_	JJ	_	_	_	_	_
5	with	_	_	IN	_	_	_	_	_
6	our	_	_	PRP$	_	_	_	_	_
7	findings	_	_	NNS	_	_	_	_	_
8	as	_	_	IN	_	_	_	_	_
9	Si	_	_	NNP	_	_	_	_	_
10	is	_	_	VBZ	_	_	_	_	_
11	supposed	_	_	VBN	_	_	_	_	_
12	to	_	_	TO	_	_	_	_	_
13	contribute	_	_	VB	_	_	_	_	_
14	to	_	_	TO	_	_	_	_	_
15	biological	_	_	JJ	_	_	_	_	_
16	function	_	_	NN	_	_	_	_	_
17	and	_	_	CC	_	_	_	_	_
18	affect	_	_	VB	_	_	_	_	_
19	retention	_	_	NN	_	_	_	_	_
20	or	_	_	CC	_	_	_	_	_
21	function	_	_	NN	_	_	_	_	_
22	of	_	_	IN	_	_	_	_	_
23	other	_	_	JJ	_	_	_	_	_
24	minerals	_	_	NNS	_	_	_	_	_
25	,	_	_	,	_	_	_	_	_
26	such	_	_	JJ	_	_	_	_	_
27	as	_	_	IN	_	_	_	_	_
28	aluminum	_	_	NN	_	_	_	_	_
29	or	_	_	CC	_	_	_	_	_
30	magnesium	_	_	NN	_	_	_	_	_
31	.	_	_	.	_	_	_	_	_


1	Various	_	_	JJ	_	_	_	_	_
2	mechanisms	_	_	NNS	_	_	_	_	_
3	are	_	_	VBP	_	_	_	_	_
4	potentially	_	_	RB	_	_	_	_	_
5	involved	_	_	VBN	_	_	_	_	_
6	in	_	_	IN	_	_	_	_	_
7	the	_	_	DT	_	_	_	_	_
8	beneficial	_	_	JJ	_	_	_	_	_
9	effects	_	_	NNS	_	_	_	_	_
10	of	_	_	IN	_	_	_	_	_
11	Si	_	_	NN	_	_	_	_	_
12	.	_	_	.	_	_	_	_	_


1	Here	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	a	_	_	DT	_	_	_	_	_
4	major	_	_	JJ	_	_	_	_	_
5	result	_	_	NN	_	_	_	_	_
6	in	_	_	IN	_	_	_	_	_
7	our	_	_	PRP$	_	_	_	_	_
8	study	_	_	NN	_	_	_	_	_
9	is	_	_	VBZ	_	_	_	_	_
10	that	_	_	IN	_	_	_	_	_
11	SpSi	_	_	NNP	_	_	_	_	_
12	supplementation	_	_	NN	_	_	_	_	_
13	reverses	_	_	VBZ	_	_	_	_	_
14	elastic	_	_	JJ	_	_	_	_	_
15	fiber	_	_	NN	_	_	_	_	_
16	degradation	_	_	NN	_	_	_	_	_
17	which	_	_	WDT	_	_	_	_	_
18	is	_	_	VBZ	_	_	_	_	_
19	likely	_	_	JJ	_	_	_	_	_
20	to	_	_	TO	_	_	_	_	_
21	contribute	_	_	VB	_	_	_	_	_
22	to	_	_	TO	_	_	_	_	_
23	the	_	_	DT	_	_	_	_	_
24	overall	_	_	JJ	_	_	_	_	_
25	benefit	_	_	NN	_	_	_	_	_
26	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	observed	_	_	VBN	_	_	_	_	_
3	regenerative	_	_	JJ	_	_	_	_	_
4	changes	_	_	NNS	_	_	_	_	_
5	of	_	_	IN	_	_	_	_	_
6	the	_	_	DT	_	_	_	_	_
7	vascular	_	_	JJ	_	_	_	_	_
8	wall	_	_	NN	_	_	_	_	_
9	are	_	_	VBP	_	_	_	_	_
10	in	_	_	IN	_	_	_	_	_
11	line	_	_	NN	_	_	_	_	_
12	with	_	_	IN	_	_	_	_	_
13	a	_	_	DT	_	_	_	_	_
14	Si-related	_	_	JJ	_	_	_	_	_
15	beneficial	_	_	JJ	_	_	_	_	_
16	effect	_	_	NN	_	_	_	_	_
17	.	_	_	.	_	_	_	_	_


1	However	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	quantification	_	_	NN	_	_	_	_	_
4	of	_	_	IN	_	_	_	_	_
5	Si	_	_	NN	_	_	_	_	_
6	level	_	_	NN	_	_	_	_	_
7	in	_	_	IN	_	_	_	_	_
8	the	_	_	DT	_	_	_	_	_
9	aortic	_	_	JJ	_	_	_	_	_
10	tissue	_	_	NN	_	_	_	_	_
11	is	_	_	VBZ	_	_	_	_	_
12	warranted	_	_	VBN	_	_	_	_	_
13	to	_	_	TO	_	_	_	_	_
14	validate	_	_	VB	_	_	_	_	_
15	this	_	_	DT	_	_	_	_	_
16	hypothesis	_	_	NN	_	_	_	_	_
17	.	_	_	.	_	_	_	_	_

